MedMen Enterprises Inc MMNFF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MMNFF is a good fit for your portfolio.
News
-
MedMen goes from height of $3 billion valuation to zero as stock draws cease-trade order and top execs leave
-
MedMen appoints Ellen Deutsch as CEO
-
MedMen CFO Bowman resigns
-
Federal judge clears New York to issue cannabis licenses in all regions but one
-
Cannabis exec Adam Bierman wins MedMen arbitration settlement and eyes pot biz again
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.04
- Bid/Ask
- $0.01 / $0.01
- Market Cap
- $1,383.20
- Volume/Avg
- 6,100 / 152,375
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,370
- Website
- https://www.medmen.com
Valuation
|
Metric
|
MMNFF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
MMNFF
Financial Strength
|
Metric
|
MMNFF
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.19 |
Interest Coverage | −3.55 |
Quick Ratio
MMNFF
Profitability
|
Metric
|
MMNFF
|
|---|---|
Return on Assets (Normalized) | −19.36% |
Return on Equity (Normalized) | −35.94% |
Return on Invested Capital (Normalized) | −32.44% |
Return on Assets
MMNFF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Fdjvfyrs | Nnhsf | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Ktllhstdn | Kddwr | $68.4 Bil | |
HLN
| Haleon PLC ADR | Dmcwhdw | Qdc | $37.0 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Dbkypsyv | Rrcvn | $14.5 Bil | |
VTRS
| Viatris Inc | Mbhrfcn | Ncn | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qcdtztm | Jcdk | $12.0 Bil | |
CTLT
| Catalent Inc | Zcxjqrqds | Rdpsjn | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Vcfxtgch | Xmkp | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Rwzgzkgpj | Gxm | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Lxkkqyr | Rnpjgr | $3.5 Bil |